Axxcess Wealth Management, LLC Synthetic Biologics, Inc. Transaction History

Axxcess Wealth Management, LLC

  • $3.61 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.9 - $2.9 $19,190 - $29,290
-10,100 Closed
0 $0
Q1 2022

Aug 11, 2022
BUY
$2.3 - $4.3 $23,230 - $43,430
10,100 New
10,100 $3,000

About Synthetic Biologics, Inc.

SYN Quotes by TradingView
  • Ticker SYN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 15,844,100
  • Market Cap $9.51M
  • Description
  • Synthetic Biologics, Inc., a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. The company's lead product candidates include SYN-004 designed to degrade various commonly used intravenous beta-lactam antibiotics in gastrointestinal (GI) tract for the prevention of microbiome damage, clostridium difficile...
More about SYN
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email